{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:44:52Z","timestamp":1793119492849,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"DOI":"10.1007\/s10103-025-04327-9","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:37:20Z","timestamp":1738802240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The evolving landscape of laser-based skin cancer prevention"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5928-5042","authenticated-orcid":false,"given":"Emily","family":"Wenande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2497-4646","authenticated-orcid":false,"given":"Fernanda H.","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3725-0284","authenticated-orcid":false,"given":"Uwe","family":"Paasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1250-2035","authenticated-orcid":false,"given":"Merete","family":"Haedersdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"issue":"10","key":"4327_CR1","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamadermatol.2015.1187","volume":"151","author":"HW Rogers","year":"2015","unstructured":"Rogers HW, Weinstock MA, Feldman SR, Coldiron BM (2015) Incidence Estimate of Nonmelanoma skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012. JAMA Dermatol 151(10):1081\u20131086","journal-title":"JAMA Dermatol"},{"key":"4327_CR2","unstructured":"Salah S, Khurana K, Balan D et al (2023) A comprehensive analysis of global skin cancer incidence and mortality with a focus on dermatologist density and population risk factors. Presented EADV Congress 11 October; Berlin2023."},{"issue":"4","key":"4327_CR3","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/jamadermatol.2014.3307","volume":"151","author":"MR Wehner","year":"2015","unstructured":"Wehner MR, Linos E, Parvataneni R et al (2015) Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma. JAMA Dermatol 151(4):382\u2013388","journal-title":"JAMA Dermatol"},{"issue":"2","key":"4327_CR4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.amepre.2014.08.036","volume":"48","author":"GP Guy Jr","year":"2015","unstructured":"Guy GP Jr., Machlin SR, Ekwueme DU, Yabroff KR (2015) Prevalence and costs of skin cancer treatment in the U.S., 2002\u20132006 and 2007\u20132011. Am J Prev Med 48(2):183\u2013187","journal-title":"Am J Prev Med"},{"issue":"3","key":"4327_CR5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1067\/mjd.2003.186","volume":"48","author":"TS Housman","year":"2003","unstructured":"Housman TS, Feldman SR, Williford PM et al (2003) Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol 48(3):425\u2013429","journal-title":"J Am Acad Dermatol"},{"key":"4327_CR6","unstructured":"The Surgeon General\u2019s Call to Action to Prevent Skin Cancer (2014) U.S. Washington, DC: U.S. Dept of Health and Human Services, Office of the Surgeon General"},{"key":"4327_CR7","unstructured":"Practice Safe Sun American Academy of Dermatology; [updated April 18th, 2022. Available from: https:\/\/www.aad.org\/public\/everyday-care\/sun-protection\/shade-clothing-sunscreen\/practice-safe-sun"},{"issue":"6","key":"4327_CR8","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s00403-023-02547-z","volume":"315","author":"C Mckenzie","year":"2023","unstructured":"Mckenzie C, Nahm WJ, Kearney CAZ (2023) Sun-protective behaviors and sunburn among US adults. Arch Dermatol Res 315(6):1665\u20131674","journal-title":"Arch Dermatol Res"},{"key":"4327_CR9","unstructured":"New American Academy of Dermatology survey reveals most Americans say sun protection is more important now than five years ago, yet many misunderstand how to protect themselves. April 26, 2022 [Available from: https:\/\/www.aad.org\/news\/new-aad-survey-reveals-growing-importance-sun-protection"},{"issue":"2","key":"4327_CR10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jaad.2021.03.109","volume":"85","author":"P Aggarwal","year":"2021","unstructured":"Aggarwal P, Knabel P, Fleischer AB (2021) Jr. United States burden of melanoma and non-melanoma skin cancer from 1990 to 2019. J Am Acad Dermatol 85(2):388\u2013395","journal-title":"J Am Acad Dermatol"},{"issue":"4989","key":"4327_CR11","first-page":"1","volume":"24","author":"D Arcuni","year":"2023","unstructured":"Arcuni D, Ramchatesingh B, Lagace F et al (2023) Pharmacological agents used in the Prevention and Treatment of Actinic Keratosis: a review. Int J Mol Sci 24(4989):1\u201326","journal-title":"Int J Mol Sci"},{"issue":"17","key":"4327_CR12","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa1506197","volume":"373","author":"AC Chen","year":"2015","unstructured":"Chen AC, Martin AJ, Choy B et al (2015) A phase 3 Randomized Trial of Nicotinamide for skin-Cancer chemoprevention. N Engl J Med 373(17):1618\u20131626","journal-title":"N Engl J Med"},{"issue":"4","key":"4327_CR13","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jaad.2018.11.024","volume":"80","author":"R Neugebauer","year":"2019","unstructured":"Neugebauer R, Su KA, Zhu Z et al (2019) Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: a cohort study. J Am Acad Dermatol 80(4):998\u20131005","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"4327_CR14","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/dsu.12138","volume":"39","author":"JB Travers","year":"2013","unstructured":"Travers JB, Spandau DF, Lewis DA et al (2013) Fibroblast senescence and squamous cell carcinoma: how wounding therapies could be protective. Dermatol Surg 39(7):967\u2013973","journal-title":"Dermatol Surg"},{"key":"4327_CR15","doi-asserted-by":"crossref","first-page":"813132","DOI":"10.3389\/fonc.2021.813132","volume":"11","author":"TC Frommeyer","year":"2021","unstructured":"Frommeyer TC, Rohan CA, Spandau DF et al (2021) Wounding therapies for Prevention of Photocarcinogenesis. Front Oncol 11:813132","journal-title":"Front Oncol"},{"issue":"7968","key":"4327_CR16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41586-023-06198-y","volume":"619","author":"S Gallini","year":"2023","unstructured":"Gallini S, Annusver K, Rahman NT et al (2023) Injury prevents Ras mutant cell expansion in mosaic skin. Nature 619(7968):167\u2013175","journal-title":"Nature"},{"key":"4327_CR17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1172\/JCI150972","volume":"131","author":"DF Spandau","year":"2021","unstructured":"Spandau DF, Chen R, Wargo JJ et al (2021) Randomized controlled trial of fractionated laser resurfacing on aged skin as prophylaxis against actinic neoplasia. J Clin Invest 131:19","journal-title":"J Clin Invest"},{"issue":"2","key":"4327_CR18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/DSS.0000000000003672","volume":"49","author":"TA Benson","year":"2023","unstructured":"Benson TA, Hibler BP, Kotliar D, Avram M (2023) Nonablative fractional laser treatment is Associated with a decreased risk of subsequent facial keratinocyte Carcinoma Development. Dermatol Surg 49(2):149\u2013154","journal-title":"Dermatol Surg"},{"issue":"1","key":"4327_CR19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/lsm.23613","volume":"55","author":"UH Olesen","year":"2023","unstructured":"Olesen UH, Jacobsen K, Lerche CM, Haedersdal M (2023) Repeated exposure to fractional CO(2) laser delays squamous cell carcinoma formation and prevents clinical and subclinical photodamage visualized by line-field confocal optical coherence tomography and histology. Lasers Surg Med 55(1):73\u201381","journal-title":"Lasers Surg Med"},{"issue":"3","key":"4327_CR20","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/DSS.0000000000000298","volume":"41","author":"J Gye","year":"2015","unstructured":"Gye J, Ahn SK, Kwon JE, Hong SP (2015) Use of fractional CO2 laser decreases the risk of skin cancer development during ultraviolet exposure in hairless mice. Dermatol Surg 41(3):378\u2013386","journal-title":"Dermatol Surg"},{"issue":"10","key":"4327_CR21","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1524-4725.1997.tb00741.x","volume":"23","author":"SJ Trimas","year":"1997","unstructured":"Trimas SJ, Ellis DA, Metz RD (1997) The carbon dioxide laser. An alternative for the treatment of actinically damaged skin. Dermatol Surg 23(10):885\u2013889","journal-title":"Dermatol Surg"},{"issue":"8","key":"4327_CR22","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1001\/archderm.142.8.976","volume":"142","author":"BM Hantash","year":"2006","unstructured":"Hantash BM, Stewart DB, Cooper ZA et al (2006) Facial resurfacing for nonmelanoma skin cancer prophylaxis. Arch Dermatol 142(8):976\u2013982","journal-title":"Arch Dermatol"},{"issue":"5","key":"4327_CR23","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/lsm.20048","volume":"34","author":"D Manstein","year":"2004","unstructured":"Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR (2004) Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med 34(5):426\u2013438","journal-title":"Lasers Surg Med"},{"key":"4327_CR24","volume-title":"Evidence-based practice in nursing and healthcare. A guide to best practice","author":"M Melnyk","year":"2011","unstructured":"Melnyk M, Fineout-Overholt E (2011) Evidence-based practice in nursing and healthcare. A guide to best practice. Lippincott, Williams & Wilkins, Philidelphia"},{"issue":"1","key":"4327_CR25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/lsm.23175","volume":"52","author":"R Chen","year":"2020","unstructured":"Chen R, Wargo JJ, Williams A et al (2020) Single ablative fractional resurfacing laser treatment for Forearm Actinic keratoses: 6-Month Follow-Up data from an Intrapatient comparison between treated and untreated sites. Lasers Surg Med 52(1):84\u201387","journal-title":"Lasers Surg Med"},{"issue":"7","key":"4327_CR26","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/lsm.23680","volume":"55","author":"E Trovato","year":"2023","unstructured":"Trovato E, Fiorani D, Cartocci A, Cinotti E, Rubegni P (2023) IGF1 synthesis after CO(2) fractional laser resurfacing (FLR): new insights in the treatment of scalp actinic keratoses. Lasers Surg Med 55(7):642\u2013652","journal-title":"Lasers Surg Med"},{"issue":"8","key":"4327_CR27","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3109\/02656736.2011.595380","volume":"27","author":"S Grunewald","year":"2011","unstructured":"Grunewald S, Bodendorf M, Illes M et al (2011) In vivo wound healing and dermal matrix remodelling in response to fractional CO(2) laser intervention: clinicopathological correlation in non-facial skin. Int J Hyperth 27(8):811\u2013818","journal-title":"Int J Hyperth"},{"issue":"2","key":"4327_CR28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/14764172.2020.1728339","volume":"22","author":"U Paasch","year":"2020","unstructured":"Paasch U, Said T (2020) Stimulation of collagen and elastin production in-vivo using 1,540 nm Er:Glass laser: assessment of safety and efficacy. J Cosmet Laser Ther 22(2):77\u201383","journal-title":"J Cosmet Laser Ther"},{"issue":"6","key":"4327_CR29","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/jid.2012.29","volume":"132","author":"DF Spandau","year":"2012","unstructured":"Spandau DF, Lewis DA, Somani AK, Travers JB (2012) Fractionated laser resurfacing corrects the inappropriate UVB response in geriatric skin. J Invest Dermatol 132(6):1591\u20131596","journal-title":"J Invest Dermatol"},{"issue":"19","key":"4327_CR30","doi-asserted-by":"crossref","first-page":"eadf2384","DOI":"10.1126\/sciadv.adf2384","volume":"9","author":"HY Wong","year":"2023","unstructured":"Wong HY, Lee RC, Chong S et al (2023) Epidermal mutation accumulation in photodamaged skin is associated with skin cancer burden and can be targeted through ablative therapy. Sci Adv 9(19):eadf2384","journal-title":"Sci Adv"},{"issue":"6","key":"4327_CR31","first-page":"583","volume":"43","author":"LM David","year":"1989","unstructured":"David LM, Lask GP, Glassberg E, Jacoby R, Abergel RP (1989) Laser abrasion for cosmetic and medical treatment of facial actinic damage. Cutis 43(6):583\u2013587","journal-title":"Cutis"},{"issue":"8","key":"4327_CR32","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/DSS.0000000000001527","volume":"44","author":"J Borges","year":"2018","unstructured":"Borges J, Araujo L, de Oliveira RPB, Manela-Azulay M (2018) Effects of 1,540-nm fractional nonablative erbium and 2,940-nm fractional ablative erbium on p53 epidermal expression after 3 months: a Split-Face Interventional Study. Dermatol Surg 44(8):1109\u20131114","journal-title":"Dermatol Surg"},{"issue":"6","key":"4327_CR33","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/dsu.12145","volume":"39","author":"M El-Domyati","year":"2013","unstructured":"El-Domyati M, El-Ammawi TS, Medhat W et al (2013) Expression of p53 protein after nonablative rejuvenation: the other side of the coin. Dermatol Surg 39(6):934\u2013943","journal-title":"Dermatol Surg"},{"issue":"3","key":"4327_CR34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.taap.2006.12.006","volume":"224","author":"CL Benjamin","year":"2007","unstructured":"Benjamin CL, Ananthaswamy HN (2007) p53 and the pathogenesis of skin cancer. Toxicol Appl Pharmacol 224(3):241\u2013248","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"4327_CR35","first-page":"668","volume":"33","author":"MM El-Domyati","year":"2007","unstructured":"El-Domyati MM, Attia SK, Esmat AM et al (2007) Effect of laser resurfacing on p53 expression in photoaged facial skin. Dermatol Surg 33(6):668\u2013675","journal-title":"Dermatol Surg"},{"issue":"9","key":"4327_CR36","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archderm.140.9.1073","volume":"140","author":"JS Orringer","year":"2004","unstructured":"Orringer JS, Johnson TM, Kang S et al (2004) Effect of carbon dioxide laser resurfacing on epidermal p53 immunostaining in photodamaged skin. Arch Dermatol 140(9):1073\u20131077","journal-title":"Arch Dermatol"},{"issue":"1","key":"4327_CR37","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/jid.2009.205","volume":"130","author":"M Purschke","year":"2010","unstructured":"Purschke M, Laubach HJ, Anderson RR, Manstein D (2010) Thermal injury causes DNA damage and lethality in unheated surrounding cells: active thermal bystander effect. J Invest Dermatol 130(1):86\u201392","journal-title":"J Invest Dermatol"},{"issue":"10","key":"4327_CR38","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/onc.2009.440","volume":"29","author":"DA Lewis","year":"2010","unstructured":"Lewis DA, Travers JB, Somani AK, Spandau DF (2010) The IGF-1\/IGF-1R signaling axis in the skin: a new role for the dermis in aging-associated skin cancer. Oncogene 29(10):1475\u20131485","journal-title":"Oncogene"},{"issue":"4","key":"4327_CR39","doi-asserted-by":"crossref","first-page":"407","DOI":"10.18632\/aging.100318","volume":"3","author":"DA Lewis","year":"2011","unstructured":"Lewis DA, Travers JB, Machado C, Somani AK, Spandau DF (2011) Reversing the aging stromal phenotype prevents carcinoma initiation. Aging 3(4):407\u2013416","journal-title":"Aging"},{"issue":"4","key":"4327_CR40","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/acel.12219","volume":"13","author":"D Tran","year":"2014","unstructured":"Tran D, Bergholz J, Zhang H et al (2014) Insulin-like growth factor-1 regulates the SIRT1-p53 pathway in cellular senescence. Aging Cell 13(4):669\u2013678","journal-title":"Aging Cell"},{"key":"4327_CR41","unstructured":"Hibler BP, Kagha K, Wilson B et al (eds) (2023) Impact of Chemical Peel and Fractional Non-ablative Laser on Predisposition to Skin Cancer Development in Elderly Skin. American Society for Dermatologic Surgery (ASDS) Annual Meeting; Nov 2\u20135; Chicago, Illinois, USA"},{"issue":"1","key":"4327_CR42","doi-asserted-by":"crossref","first-page":"12751","DOI":"10.1038\/s41598-017-13095-8","volume":"7","author":"M Kawakubo","year":"2017","unstructured":"Kawakubo M, Cunningham TJ, Demehri S, Manstein D (2017) Fractional laser releases tumor-Associated antigens in Poorly Immunogenic Tumor and induces systemic immunity. Sci Rep 7(1):12751","journal-title":"Sci Rep"},{"issue":"9","key":"4327_CR43","doi-asserted-by":"crossref","first-page":"e0184852","DOI":"10.1371\/journal.pone.0184852","volume":"12","author":"M Kawakubo","year":"2017","unstructured":"Kawakubo M, Demehri S, Manstein D (2017) Fractional laser exposure induces neutrophil infiltration (N1 phenotype) into the tumor and stimulates systemic anti-tumor immune response. PLoS ONE 12(9):e0184852","journal-title":"PLoS ONE"},{"key":"4327_CR44","doi-asserted-by":"crossref","unstructured":"Omland SH, Wenande EC, Svane IM et al (2021) Laser immunotherapy: a potential treatment modality for keratinocyte carcinoma. Cancers (Basel). 13(21)","DOI":"10.3390\/cancers13215405"},{"key":"4327_CR45","doi-asserted-by":"crossref","unstructured":"Olesen UH, Wiinberg M, Lerche CM et al (2021) Anti-PD-1 therapy with adjuvant ablative fractional laser improves Anti-tumor response in basal cell carcinomas. Cancers (Basel). 13(24)","DOI":"10.3390\/cancers13246326"},{"key":"4327_CR46","doi-asserted-by":"crossref","unstructured":"Omland SH, Ejlertsen JS, Krustrup D et al (2022) Feasibility of Intratumoral Anti-PD1 as treatment of human basal cell carcinoma: an explorative study with adjuvant ablative fractional laser. Cancers (Basel). 14(23)","DOI":"10.3390\/cancers14235815"},{"issue":"9","key":"4327_CR47","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/lsm.23406","volume":"53","author":"S Fontenete","year":"2021","unstructured":"Fontenete S, Lerche CM, Paasch U et al (2021) Tumor Clearance and Immune Cell Recruitment in UV-Induced Murine squamous cell carcinoma exposed to ablative fractional laser and Imiquimod Treatment. Lasers Surg Med 53(9):1227\u20131237","journal-title":"Lasers Surg Med"},{"issue":"1","key":"4327_CR48","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","volume":"9","author":"ZR Chalmers","year":"2017","unstructured":"Chalmers ZR, Connelly CF, Fabrizio D et al (2017) Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med 9(1):34","journal-title":"Genome Med"},{"key":"4327_CR49","doi-asserted-by":"crossref","unstructured":"Bottomley MJ, Thomson J, Harwood C, Leigh I (2019) The role of the Immune System in cutaneous squamous cell carcinoma. Int J Mol Sci. 20(8)","DOI":"10.3390\/ijms20082009"},{"issue":"3","key":"4327_CR50","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/bjd.20389","volume":"185","author":"A Tisack","year":"2021","unstructured":"Tisack A, Fotouhi A, Fidai C et al (2021) A clinical and biological review of keratoacanthoma. Br J Dermatol 185(3):487\u2013498","journal-title":"Br J Dermatol"},{"issue":"6","key":"4327_CR51","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1111\/jocd.16182","volume":"23","author":"R Nanda","year":"2024","unstructured":"Nanda R, Cohen JL (2024) Spontaneous resolution of eruptive papules following ablative laser resurfacing-case report and review of laser-associated eruptive keratoacanthomas. J Cosmet Dermatol 23(6):1936\u20131939","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"4327_CR52","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaad.2012.05.033","volume":"68","author":"ET Weiss","year":"2013","unstructured":"Weiss ET, Brauer JA, Anolik R et al (2013) 1927-nm fractional resurfacing of facial actinic keratoses: a promising new therapeutic option. J Am Acad Dermatol 68(1):98\u2013102","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"4327_CR53","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jaad.2011.02.014","volume":"65","author":"TM Katz","year":"2011","unstructured":"Katz TM, Goldberg LH, Marquez D et al (2011) Nonablative fractional photothermolysis for facial actinic keratoses: 6-month follow-up with histologic evaluation. J Am Acad Dermatol 65(2):349\u2013356","journal-title":"J Am Acad Dermatol"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-025-04327-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-025-04327-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-025-04327-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T19:03:00Z","timestamp":1771441380000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-025-04327-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4327"],"URL":"https:\/\/doi.org\/10.1007\/s10103-025-04327-9","relation":{},"ISSN":["1435-604X"],"issn-type":[{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]},"assertion":[{"value":"7 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Verbal and written consent to publish anonymized patient photographs (Figure\n                      \n                      ) in this review article has been obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval\/consent to participate\/publication"}},{"value":"With no relation to the work, Emily Wenande has received a speaker honorarium from Sanofi. With no relation to the work, EW has been employed in the pharmaceutical medicine physician (PMP) programme at Novo Nordisk A\/S since September 2024. Molly Wanner: grant funding and equipment from Bausch Health\/Solta; equity and consulting for Ella Ola, Sorette; scientific advisory board and consulting for Nu Skin; investment in Clarity Cosmetics and Lightwater. Fernanda H Sakamoto: scientific consultant for Beiersdorf and Accure laser; founder of LightWater Bioscience and royalties from Massachusetts General Hospital. Uwe Paasch: equipment from Fotona, GME Medical, Alma Lasers, Zimmer, Canfield, and FotoFinder; research grants from Zimmer; consulting fees\/speaker honoraria from Alma Lasers, Fotona, Landsberg, Galderma, DDL, DGPRAEC and Quintessenz publishing. Merete Haedersdal: equipment from Cynosure, GME Medical, and Lutronic; research grants from Galderma, Leo Pharma, L\u2019Or\u00e9al\/La Roche-Posay; and consulting fees\/speaker honoraria from La Roche-Posay, Galderma and Sanofi.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"70"}}